Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,780 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Screen2Prevent (S2P)

NCT07728123

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • University of South Florida Tampa, Florida, United States
  • Emory Atlanta Adolescent Consortium Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Recruiting

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

NCT07105059

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

NCT07355218

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Cutaneous Lupus Erythematosus, +7 more
Locations
  • Inland Rheumatology Clinical Trials, Inc. Upland, California, United States
  • Omega Research Debary, LLC DeBary, Florida, United States
  • South Florida Rheumatology Hollywood, Florida, United States
  • GTL Medical And Research Group Miami, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

NCT07282574

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Southern Neurology Kogarah, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View all 108 locations
View Trial Details
Recruiting

Dymista in Chinese Adolescents

NCT07597473

Conditions
Allergic Rhinitis Due to Allergens, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations
  • Capital Center for Children's Health, Capital Medical University Beijing, China
  • Hunan Provincial People's Hospital Changsha, China
  • The Third XiangyaHospital of Central South University Changsha, China
  • Sichuan Provincial People's Hospital Chengdu, China
View all 15 locations
View Trial Details

Related conditions